GLYC – glycomimetics, inc. (US:NASDAQ)
Stock Stats
News
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC
Form 10-Q GLYCOMIMETICS INC For: Sep 30
Form SC 13G/A GLYCOMIMETICS INC Filed by: Invus Global Management, LLC
Form DEFA14A GLYCOMIMETICS INC
Form 8-K GLYCOMIMETICS INC For: Nov 07
Form SC 13G GLYCOMIMETICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.